{"id":2162,"date":"2024-03-11T09:45:14","date_gmt":"2024-03-11T13:45:14","guid":{"rendered":"https:\/\/happylungsproject.org\/?p=2162"},"modified":"2026-03-02T10:53:33","modified_gmt":"2026-03-02T15:53:33","slug":"ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda","status":"publish","type":"post","link":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/","title":{"rendered":"RET inhibitor Granted Fast Track by FDA"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][divider line_type=”No Line” custom_height=”20″][vc_column_text text_direction=”default”]\n

Ellipses\u2019 next generation selective RET inhibitor EP0031\/A400 granted Fast Track designation by FDA<\/h2>\n

Ellipses Pharma announced that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its next generation selective RET inhibitor EP0031\/A400 for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC). The FDA grants Fast Track designation to facilitate the development and expedite the review of medicines to treat serious conditions and fill an unmet medical need.<\/p>\n

For more information:<\/p>\n

https:\/\/ellipses.life\/ellipses-next-generation-selective-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/<\/a><\/p>\n

 <\/p>\n

Learn more about The Happy Lungs Supported RET Cancer research here<\/a>.[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none”…<\/p>\n","protected":false},"author":15,"featured_media":2164,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":{"0":"post-2162","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-treatment"},"yoast_head":"\nEllipses\u2019 RET inhibitor EP0031\/A400 Granted Fast Track by FDA - The Happy Lungs Project<\/title>\n<meta name=\"description\" content=\"Ellipses Pharma received Fast Track designation for EP0031\/A400 for treating RET-fusion positive Non-Small Cell Lung Cancer (NSCLC).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ellipses\u2019 RET inhibitor EP0031\/A400 Granted Fast Track by FDA - The Happy Lungs Project\" \/>\n<meta property=\"og:description\" content=\"Ellipses Pharma received Fast Track designation for EP0031\/A400 for treating RET-fusion positive Non-Small Cell Lung Cancer (NSCLC).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"The Happy Lungs Project\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thehappylungsproject\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-11T13:45:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T15:53:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"518\" \/>\n\t<meta property=\"og:image:height\" content=\"228\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Irene Guijarro Munoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Irene Guijarro Munoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/\"},\"author\":{\"name\":\"Irene Guijarro Munoz\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\"},\"headline\":\"RET inhibitor Granted Fast Track by FDA\",\"datePublished\":\"2024-03-11T13:45:14+00:00\",\"dateModified\":\"2026-03-02T15:53:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/\"},\"wordCount\":282,\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg\",\"articleSection\":[\"Treatment\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/\",\"url\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/\",\"name\":\"Ellipses\u2019 RET inhibitor EP0031\/A400 Granted Fast Track by FDA - The Happy Lungs Project\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg\",\"datePublished\":\"2024-03-11T13:45:14+00:00\",\"dateModified\":\"2026-03-02T15:53:33+00:00\",\"description\":\"Ellipses Pharma received Fast Track designation for EP0031\/A400 for treating RET-fusion positive Non-Small Cell Lung Cancer (NSCLC).\",\"breadcrumb\":{\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg\",\"width\":518,\"height\":228,\"caption\":\"elipses pharma ep0031\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/happylungsproject.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RET inhibitor Granted Fast Track by FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/happylungsproject.org\/#website\",\"url\":\"https:\/\/happylungsproject.org\/\",\"name\":\"The Happy Lungs Project\",\"description\":\"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.\",\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/happylungsproject.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/happylungsproject.org\/#organization\",\"name\":\"The Happy Lungs Project\",\"url\":\"https:\/\/happylungsproject.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"width\":1500,\"height\":1575,\"caption\":\"The Happy Lungs Project\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/thehappylungsproject\",\"https:\/\/www.instagram.com\/thehappylungsproject\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\",\"name\":\"Irene Guijarro Munoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"caption\":\"Irene Guijarro Munoz\"},\"description\":\"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.\",\"sameAs\":[\"https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ellipses\u2019 RET inhibitor EP0031\/A400 Granted Fast Track by FDA - The Happy Lungs Project","description":"Ellipses Pharma received Fast Track designation for EP0031\/A400 for treating RET-fusion positive Non-Small Cell Lung Cancer (NSCLC).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/","og_locale":"en_US","og_type":"article","og_title":"Ellipses\u2019 RET inhibitor EP0031\/A400 Granted Fast Track by FDA - The Happy Lungs Project","og_description":"Ellipses Pharma received Fast Track designation for EP0031\/A400 for treating RET-fusion positive Non-Small Cell Lung Cancer (NSCLC).","og_url":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/","og_site_name":"The Happy Lungs Project","article_publisher":"https:\/\/www.facebook.com\/thehappylungsproject","article_published_time":"2024-03-11T13:45:14+00:00","article_modified_time":"2026-03-02T15:53:33+00:00","og_image":[{"width":518,"height":228,"url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg","type":"image\/jpeg"}],"author":"Irene Guijarro Munoz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Irene Guijarro Munoz","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#article","isPartOf":{"@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/"},"author":{"name":"Irene Guijarro Munoz","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b"},"headline":"RET inhibitor Granted Fast Track by FDA","datePublished":"2024-03-11T13:45:14+00:00","dateModified":"2026-03-02T15:53:33+00:00","mainEntityOfPage":{"@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/"},"wordCount":282,"publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"image":{"@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg","articleSection":["Treatment"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/","url":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/","name":"Ellipses\u2019 RET inhibitor EP0031\/A400 Granted Fast Track by FDA - The Happy Lungs Project","isPartOf":{"@id":"https:\/\/happylungsproject.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage"},"image":{"@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg","datePublished":"2024-03-11T13:45:14+00:00","dateModified":"2026-03-02T15:53:33+00:00","description":"Ellipses Pharma received Fast Track designation for EP0031\/A400 for treating RET-fusion positive Non-Small Cell Lung Cancer (NSCLC).","breadcrumb":{"@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#primaryimage","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/03\/elipses-pharma-ep0031.jpg","width":518,"height":228,"caption":"elipses pharma ep0031"},{"@type":"BreadcrumbList","@id":"https:\/\/happylungsproject.org\/ellipses-ret-inhibitor-ep0031-a400-granted-fast-track-designation-by-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/happylungsproject.org\/"},{"@type":"ListItem","position":2,"name":"RET inhibitor Granted Fast Track by FDA"}]},{"@type":"WebSite","@id":"https:\/\/happylungsproject.org\/#website","url":"https:\/\/happylungsproject.org\/","name":"The Happy Lungs Project","description":"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.","publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/happylungsproject.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/happylungsproject.org\/#organization","name":"The Happy Lungs Project","url":"https:\/\/happylungsproject.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","width":1500,"height":1575,"caption":"The Happy Lungs Project"},"image":{"@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thehappylungsproject","https:\/\/www.instagram.com\/thehappylungsproject\/"]},{"@type":"Person","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b","name":"Irene Guijarro Munoz","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","caption":"Irene Guijarro Munoz"},"description":"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.","sameAs":["https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/2162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/comments?post=2162"}],"version-history":[{"count":2,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/2162\/revisions"}],"predecessor-version":[{"id":2703,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/2162\/revisions\/2703"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media\/2164"}],"wp:attachment":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media?parent=2162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/categories?post=2162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/tags?post=2162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}